 Silvania Da Silva Teixeira
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Triiodothyronine | 8 | 2017 | 43 | 1.200 |
Why?
| | Phosphatidylinositol 3-Kinases | 4 | 2020 | 366 | 0.810 |
Why?
| | Calcitriol | 1 | 2020 | 59 | 0.650 |
Why?
| | Vitamins | 1 | 2020 | 185 | 0.590 |
Why?
| | Insulin | 7 | 2020 | 2411 | 0.530 |
Why?
| | Diiodothyronines | 1 | 2016 | 2 | 0.530 |
Why?
| | Insulin Resistance | 4 | 2016 | 1211 | 0.450 |
Why?
| | Glucose Transporter Type 4 | 3 | 2014 | 40 | 0.430 |
Why?
| | Neurons | 2 | 2020 | 1590 | 0.370 |
Why?
| | Receptors, Calcitriol | 2 | 2022 | 55 | 0.360 |
Why?
| | Symporters | 2 | 2016 | 66 | 0.350 |
Why?
| | Thyroid Hormones | 2 | 2011 | 61 | 0.320 |
Why?
| | Receptors, Thyroid Hormone | 2 | 2008 | 21 | 0.280 |
Why?
| | Blood Glucose | 2 | 2016 | 2190 | 0.270 |
Why?
| | Sodium Iodide | 1 | 2016 | 3 | 0.250 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2017 | 195 | 0.230 |
Why?
| | Glycogen Synthase Kinase 3 | 2 | 2017 | 82 | 0.230 |
Why?
| | Valerates | 1 | 2014 | 3 | 0.230 |
Why?
| | RNA, Messenger | 3 | 2012 | 2834 | 0.210 |
Why?
| | Glucose | 3 | 2022 | 1020 | 0.200 |
Why?
| | Proinsulin | 1 | 2012 | 54 | 0.190 |
Why?
| | Glucose Transporter Type 3 | 1 | 2012 | 13 | 0.190 |
Why?
| | Muscle, Skeletal | 3 | 2016 | 1724 | 0.190 |
Why?
| | Glucose Transporter Type 1 | 1 | 2012 | 50 | 0.190 |
Why?
| | Signal Transduction | 4 | 2020 | 5081 | 0.180 |
Why?
| | Rats | 8 | 2017 | 5648 | 0.180 |
Why?
| | Glucose Intolerance | 1 | 2022 | 146 | 0.170 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2012 | 218 | 0.170 |
Why?
| | Cell Line | 3 | 2020 | 2847 | 0.170 |
Why?
| | Trans-Activators | 1 | 2012 | 398 | 0.160 |
Why?
| | Rats, Long-Evans | 1 | 2020 | 125 | 0.160 |
Why?
| | Dietary Supplements | 1 | 2014 | 561 | 0.160 |
Why?
| | Animals | 13 | 2022 | 36951 | 0.160 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2607 | 0.160 |
Why?
| | Hypothalamus | 1 | 2020 | 153 | 0.160 |
Why?
| | Transcription, Genetic | 1 | 2016 | 1457 | 0.160 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 506 | 0.150 |
Why?
| | RANK Ligand | 1 | 2008 | 29 | 0.140 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2167 | 0.140 |
Why?
| | Bone Resorption | 1 | 2008 | 86 | 0.140 |
Why?
| | Osteosarcoma | 1 | 2008 | 74 | 0.130 |
Why?
| | Osteoblasts | 1 | 2008 | 126 | 0.130 |
Why?
| | Hep G2 Cells | 1 | 2016 | 67 | 0.130 |
Why?
| | Adipose Tissue | 2 | 2016 | 635 | 0.130 |
Why?
| | Enzyme Activation | 3 | 2017 | 810 | 0.130 |
Why?
| | Neurodegenerative Diseases | 1 | 2017 | 135 | 0.120 |
Why?
| | Diet, High-Fat | 1 | 2016 | 247 | 0.120 |
Why?
| | Obesity | 2 | 2020 | 2993 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2016 | 437 | 0.110 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 436 | 0.110 |
Why?
| | Estrogens | 1 | 2008 | 367 | 0.110 |
Why?
| | Congenital Hypothyroidism | 1 | 2004 | 11 | 0.110 |
Why?
| | Rats, Wistar | 3 | 2017 | 455 | 0.110 |
Why?
| | Iodides | 1 | 2014 | 8 | 0.110 |
Why?
| | Phosphorylation | 4 | 2014 | 1759 | 0.110 |
Why?
| | Hypothyroidism | 1 | 2004 | 72 | 0.110 |
Why?
| | Thyroid Gland | 1 | 2014 | 94 | 0.100 |
Why?
| | Peptide Initiation Factors | 1 | 2012 | 16 | 0.100 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2012 | 35 | 0.100 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2012 | 29 | 0.100 |
Why?
| | Hippocampus | 1 | 2017 | 895 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2016 | 922 | 0.080 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5764 | 0.080 |
Why?
| | Male | 7 | 2022 | 67906 | 0.080 |
Why?
| | Biotinylation | 2 | 2014 | 32 | 0.080 |
Why?
| | Brain | 1 | 2021 | 2677 | 0.070 |
Why?
| | Cell Membrane | 2 | 2012 | 738 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2012 | 422 | 0.070 |
Why?
| | Reactive Oxygen Species | 2 | 2016 | 623 | 0.070 |
Why?
| | Cytokines | 1 | 2016 | 2085 | 0.070 |
Why?
| | Insulin-Secreting Cells | 1 | 2012 | 377 | 0.070 |
Why?
| | Mice | 3 | 2022 | 17794 | 0.070 |
Why?
| | PAX8 Transcription Factor | 1 | 2016 | 4 | 0.060 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2016 | 7 | 0.060 |
Why?
| | Cell Line, Tumor | 3 | 2012 | 3415 | 0.060 |
Why?
| | Gene Expression | 2 | 2021 | 1502 | 0.060 |
Why?
| | Thyrotropin | 1 | 2016 | 114 | 0.060 |
Why?
| | Down-Regulation | 1 | 2016 | 657 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 346 | 0.050 |
Why?
| | Dactinomycin | 1 | 2012 | 28 | 0.050 |
Why?
| | Cycloheximide | 1 | 2012 | 55 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2014 | 366 | 0.050 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2012 | 16 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 434 | 0.050 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2012 | 72 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2016 | 620 | 0.050 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2012 | 47 | 0.050 |
Why?
| | Deoxyglucose | 1 | 2012 | 53 | 0.050 |
Why?
| | Blotting, Northern | 1 | 2011 | 201 | 0.050 |
Why?
| | Blotting, Western | 1 | 2014 | 1227 | 0.050 |
Why?
| | Polyadenylation | 1 | 2011 | 42 | 0.040 |
Why?
| | Thyroidectomy | 1 | 2011 | 106 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1251 | 0.040 |
Why?
| | Mice, Inbred ICR | 1 | 2021 | 119 | 0.040 |
Why?
| | Brain Chemistry | 1 | 2021 | 117 | 0.040 |
Why?
| | Protein Transport | 1 | 2011 | 445 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 397 | 0.040 |
Why?
| | Homeostasis | 1 | 2022 | 621 | 0.040 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2008 | 26 | 0.040 |
Why?
| | Osteoclasts | 1 | 2008 | 52 | 0.030 |
Why?
| | Thyroxine | 1 | 2017 | 62 | 0.030 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2017 | 131 | 0.030 |
Why?
| | Alloxan | 1 | 2016 | 4 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 976 | 0.030 |
Why?
| | Liver | 1 | 2014 | 1943 | 0.030 |
Why?
| | Inflammasomes | 1 | 2016 | 131 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2012 | 4193 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1120 | 0.030 |
Why?
| | Anions | 1 | 2014 | 31 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3018 | 0.030 |
Why?
| | Superoxides | 1 | 2014 | 202 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2016 | 513 | 0.020 |
Why?
| | Humans | 4 | 2016 | 137782 | 0.020 |
Why?
| | Insulinoma | 1 | 2012 | 26 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 384 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2014 | 840 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2008 | 1991 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2012 | 338 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 433 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 455 | 0.020 |
Why?
| | Oxygen | 1 | 2014 | 938 | 0.020 |
Why?
| | Female | 3 | 2022 | 73465 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 6771 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 771 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2057 | 0.020 |
Why?
| | Mitochondria | 1 | 2014 | 948 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2012 | 938 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4295 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 10837 | 0.010 |
Why?
| | Middle Aged | 1 | 2008 | 33554 | 0.010 |
Why?
|
|
Da Silva Teixeira's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|